Friday at 4 p.m. With a New Anticoagulant

Decision: home is defensible, but only as home with a constructed safety net - not home as currently configured.

Reasoning: the clinical trajectory is improving (ambulation 15 → 50 feet), so she does not meet the functional threshold for SNF, and pushing for a SNF bed on a Friday afternoon would likely leave her boarding in the hospital through the weekend - a known harm. The real risks are not mobility, they are medication and monitoring.

What must be true for home to work:

1. Someone other than the patient can reliably execute the medication plan. Her husband cannot be that person. This is the single most important constraint - a fourth-grade literacy level plus a cognitively impaired spouse plus a new anticoagulant is a compounding failure, not an additive one.
2. Anticoagulation follow-up is scheduled before she leaves, with a specific date and a specific person responsible for the result.
3. Oxygen is in the home and set up before discharge, not ordered for delivery Monday.

What would change my mind toward SNF: a documented inability to get out of bed or toilet safely at home; no caregiver at all; a home assessment indicating stairs or no working utilities; or a medication regimen that cannot be simplified. If the daughter can commit to being present for the first 72 hours, that is the cheapest and most reliable intervention available - I would make that call before I make the SNF referral.

What I would not do: discharge on Friday and hope. The weekend is when this plan will be tested, and it will be tested without a clinic open.

Risks, in order of severity:

1. Aspirin plus apixaban continued together. In atrial fibrillation, dual therapy is usually not indicated unless there is a recent stent or ACS. This is a bleeding-risk issue that needs a prescriber decision - not a nursing correction. I would surface it as a question, not an instruction: "Should aspirin continue alongside the apixaban, or is that for a specific indication I should document?"
2. Dose appropriateness. Apixaban 5 mg twice daily is correct only if she does not meet two of three reduction criteria (age ≥80, weight ≤60 kg, creatinine ≥1.5). I would confirm the weight and renal function in the chart rather than assume.
3. Prednisone taper confusion - tapers are the classic source of double-dosing, especially for a patient who identifies pills by color.
4. Color-based identification fails once generic substitution changes the tablet at the retail pharmacy.

Teach-back done properly:

• Ask her to show me how she would take her pills tomorrow morning using the actual bottles - demonstration beats verbal recall at low literacy.
• Ask her to teach it back to her husband, which tests transfer to the person who will actually be there.
• Use a pictogram-based schedule with times of day, not a printed list of drug names.
• Ask one closing question that reveals the gap: "What will you do if you miss a dose of the blood thinner?"
• Do not ask "do you understand?" - that question is answered "yes" by everyone, which is why it teaches nothing.

Closing the loop, concretely:

• Two appointments, not one: a primary care or transitional care visit within 7 days, and an anticoagulation/lab check within 3–5 days if any renal function or dose question is unresolved.
• Verify the appointment exists - a name, date, time, and phone number in the discharge paperwork, not "follow up with PCP."
• Confirm transportation before she leaves, not after.
• Assign the confirm call: a 48–72 hour post-discharge phone call, owned by a named person, with a scripted question about whether the apixaban was actually picked up. The most common failure is a prescription that never gets filled, and it is invisible unless someone asks.
• Send the discharge summary to the receiving clinician with the open aspirin question flagged explicitly, so the next clinician inherits a question rather than an assumption.

If no appointment is available within 7 days:

1. Escalate to the clinic's transitional-care or post-discharge slot - many systems hold slots that are not visible on the standard schedule.
2. Consider a pharmacist-led medication management visit or a home health nursing visit as an interim safety net, if covered.
3. If neither exists, do not silently accept the gap. Document the failed attempt and the plan, and ensure the 48-hour phone call is the safety net. The unacceptable outcome is a discharge summary that reads as though follow-up was arranged when it was not.